TY - JOUR
T1 - Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function
AU - Kobayashi, Hiroki
AU - Abe, Masanori
AU - Nakamura, Yoshihiro
AU - Takahashi, Katsutoshi
AU - Fujita, Megumi
AU - Takeda, Yoshiyu
AU - Yoneda, Takashi
AU - Kurihara, Isao
AU - Itoh, Hiroshi
AU - Tsuiki, Mika
AU - Wada, Norio
AU - Ichijo, Takamasa
AU - Katabami, Takuyuki
AU - Ogawa, Yoshihiro
AU - Kawashima, Junji
AU - Yoshimoto, Takanobu
AU - Sone, Masakatsu
AU - Inagaki, Nobuya
AU - Watanabe, Minemori
AU - Kamemura, Kohei
AU - Matsuda, Yuichi
AU - Izawa, Shoichiro
AU - Tanabe, Makito
AU - Tanabe, Akiyo
AU - Suzuki, Tomoko
AU - Naruse, Mitsuhide
N1 - Funding Information:
The study was conducted according to Declaration of Helsinki Guidelines and the clinical studies published by the Japanese Ministry of Health, Labour and Welfare; approved by the National Hospital Organization Kyoto Medical Center (Kyoto, Japan) Ethics Committee (the lead center) and the institutional ethics committees of the participating centers; and registered at the University Hospital Medical Information Network (UMIN ID: 18756). The data from the JPAS study were assessed retrospectively. This study was performed using an opt-out methodology. The opt-out option was presented on the website and as a notice in a prominent place at each center.
Funding Information:
The Japan Agency for Medical Research and Development supported this study [grant numbers JP17ek0109122, JP18ek0109352].
Publisher Copyright:
© 2019 Lippincott Williams and Wilkins. All rights reserved.
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Primary aldosteronism causes renal structural damage after glomerular hyperfiltration, and primary aldosteronism-specific treatment leads to an acute fall in estimated glomerular filtration rate (eGFR). We investigated whether this change affected the long-term eGFR slope in a retrospective cohort from the multicenter Japan Primary Aldosteronism Study. We allocated patients with primary aldosteronism to the adrenalectomy (n=202) and MR (mineralocorticoid receptor) antagonist (n=303) groups based on their treatment history and analyzed the association between the initial eGFR fall and long-term eGFR slope. The increased age, low serum potassium levels, high eGFR, and high plasma aldosterone levels were independent predictors for a large initial eGFR fall in both groups. Our analysis of tertiles based on the initial eGFR fall revealed that in the MR antagonist group, patients with a small initial eGFR fall had a significantly steeper long-term eGFR slope than those with a large initial fall (tertile 1 versus 2, P=0.025; tertile 1 versus 3, P=0.017). These associations were not identified in the adrenalectomy group. Thus, the smaller the acute fall in eGFR by initiation of MR antagonists, the greater was the rate of long-term eGFR decline. While the acute fall in eGFR induced by primary aldosteronism-specific treatment is occasionally a clinical concern, our findings highlight the favorable implications of the acute fall with respect to long-term renal outcomes.
AB - Primary aldosteronism causes renal structural damage after glomerular hyperfiltration, and primary aldosteronism-specific treatment leads to an acute fall in estimated glomerular filtration rate (eGFR). We investigated whether this change affected the long-term eGFR slope in a retrospective cohort from the multicenter Japan Primary Aldosteronism Study. We allocated patients with primary aldosteronism to the adrenalectomy (n=202) and MR (mineralocorticoid receptor) antagonist (n=303) groups based on their treatment history and analyzed the association between the initial eGFR fall and long-term eGFR slope. The increased age, low serum potassium levels, high eGFR, and high plasma aldosterone levels were independent predictors for a large initial eGFR fall in both groups. Our analysis of tertiles based on the initial eGFR fall revealed that in the MR antagonist group, patients with a small initial eGFR fall had a significantly steeper long-term eGFR slope than those with a large initial fall (tertile 1 versus 2, P=0.025; tertile 1 versus 3, P=0.017). These associations were not identified in the adrenalectomy group. Thus, the smaller the acute fall in eGFR by initiation of MR antagonists, the greater was the rate of long-term eGFR decline. While the acute fall in eGFR induced by primary aldosteronism-specific treatment is occasionally a clinical concern, our findings highlight the favorable implications of the acute fall with respect to long-term renal outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85071349255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071349255&partnerID=8YFLogxK
U2 - 10.1161/HYPERTENSIONAHA.119.13131
DO - 10.1161/HYPERTENSIONAHA.119.13131
M3 - Article
C2 - 31327258
AN - SCOPUS:85071349255
SN - 0194-911X
VL - 74
SP - 630
EP - 638
JO - Hypertension
JF - Hypertension
IS - 3
ER -